Clinical Trial Update: GORE EXCLUDER® Endoprosthesis - Low Permeability in Treatment of Abdominal Aortic Aneurysms [Phase 4]

View source ↗

Summary

Phase 4 trial update for GORE EXCLUDER Endoprosthesis indicating low permeability in treating abdominal aortic aneurysms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Aneurysm Abdominal

Drugs mentioned

• GORE EXCLUDER Endoprosthesis (Endovascular aneurysm repair device)

Snippet

Sponsor: W.L.Gore & Associates | Conditions: Aortic Aneurysm, Abdominal | Phase 4 | Status: COMPLETED | Results posted: 2010-08-23